Clifford L. Klinck, Jr. Centennial Professor Emeritus in Pharmacy
Dr. Marvin Shepherd’s research interests lie in the major areas of the economics of pharmacy services, pharmaceutical marketing, importation of pharmaceuticals, prescription drug diversion, counterfeit medications, managed care pharmacy and pharmacoeconomics. He has an intense interest in conducting research that examines the policies related to drug importation and re-importation, especially from Mexico, the use of drug anti-counterfeiting strategies and techniques for monitoring prescription drug diversion. He is also involved in conducting research on the economics of pharmacy practice, such as cost of dispensing, prescription drug pricing issues, the extent of generic drug use and other policies which affect drug use within the Medicaid population. Dr. Shepherd also enjoys pharmaceutical marketing research, especially measuring the impact of direct-to-consumer drug advertising.
See also:
Marv Shepherd earned his B.S. in biology (1969) from Michigan Technological University, a B.S. in pharmacy from Ferris State University (1975), M.S. from the University of Rhode Island (1978) and Ph.D. from Purdue University (1980). In 1969, he received his commission in the U.S. Army and served with the 10th Special Forces Group (Green Berets). He is currently the Director of the Center for Pharmacoeconomic Studies College of Pharmacy.
Dr. Shepherd’s research interests have covered examining generic drug use, pharmaceutical marketing strategies including direct to consumer advertising, coupon use and pricing, the impact of the Medicare Part D prescription drug program on community pharmacies, managed care, pharmacoeconomics. He has also studied the spread of counterfeit medications and drug diversion worldwide. He has over 100 publications, six book chapters and is an editor of the textbook,Pharmacy Management Leadership, Marketing and Finance.
He has conducted research on drug importation, drug counterfeiting and drug diversion for close to 20 years. His research and expertise on drug diversion, importation and drug counterfeiting has been featured on CNN News, NPR Radio: First Edition, Newsweek, Wall Street Journal, Money Magazine, Time Magazine, Prevention Magazine, US News and World Report, New York Times, USA Today, Washington Post, plus many other national newspapers, magazines and television and radio news broadcasts. He has testified before U.S. Congress four times on drug importation, prescription drug diversion and counterfeit drugs. His research on the extent Rohypnol, (the date rape drug) was entering the U.S. from Mexico, was instrumental in the U.S. banning of the product in 1997. In 2006, he received the Award of Excellence from the American Society of Health-System Pharmacists for his work on drug counterfeiting and drug importation. By invitation from the U.S. Commerce Department, he participated in the 2008 and 2009 Anti-Counterfeit Drug Conferences in Beijing, China.
Dr. Shepherd is currently the President of the Partnership for Safe Medicines, an organization dedicated to fighting counterfeit medications, drug diversion and informing health professionals and consumers about fake, substandard and diverted drug products. In 2010, he was appointed to the Drug Packaging and Distribution Committee of the United States Pharmacopeia.
Other Interests
I am married and Valerie and I have two children, Josh and Monica who also reside in Austin, TX. Valerie and I also have two dogs, dachshunds named Lucy and Molly. They are a lot of fun and keep us busy. In addition, we are owners of some longhorn cattle. I love outdoors activities, especially fly fishing and enjoy the art and creativity of tying my own flies. I also enjoy gardening, cooking outside. I am a collector of toy Lionel trains and every holiday season I set up a large winter scene train layout.
Recent Publications
Shepherd, Marv, “Examination Why Community Pharmacists Do Not Provide 72-Hour Emergency Prescription Drugs to Medicaid Patients When Prior Authorization is Not Available” Journal of Managed Care Pharmacy, In Press.
Nemlekar, P., Shepherd, M.D. Lawson K.L. “Web-based Survey to Assess the Perceptions of Managed Care Organization Representatives on Use of Co-pay Subsidy Coupons for Prescription Drugs, Journal Managed Care Pharmacy, In Press.
Shepherd, Marv, Fake Online Pharmacy alert makes the Case for a Closed Medicine Supply, Partnership for Safe Medicines, August 9, 2011.
Scherbakova Natalia, Shepherd, Marv, Lawson Ken, Richards Kristin, The Role of Authorized Generics in the Prescription Drug Market Place, Journal of Generic Medicines, Vol. 8, No. 1, 2011, 28-40.
Gavaza Paul, Shepherd Marv, Scherbakova Natasha and Khoza Star, The State of Health Economics and Pharmacoeconomics Research in Russia: A Systematic Review, Journal of Pharmaceutical Health Services Research, 2010, No.1, 113-121.
Shepherd, Marv The Effect of the U.S. Pharmaceutical Importation on Canada s Pharmaceutical Supply, Canadian Pharmacists Journal, Vol 143, No 5, September/October 2010, 226-233.
Shepherd, Marv, Black Medicine, Americas Quarterly, Vol.4, No.3, Summer, 2010, 82-85.
Shepherd, Marv Beef Up International Cooperation on Counterfeits, Nature Medicines, Vol.16, No. 4, April 4, 2010
Winegar Angela, Shepherd Marvin, Lawson Kenneth and Richards Kristin, Comparison of Claim Percent Gross Margin Earned by Texas Community Independent Pharmacies for Dual-Eligible Beneficiaries Claims Before and After Medicare Part D, Journal of the American Pharmacists Association,September/October 2009.
Shepherd, Marv, Richards, Kristin, Winegar, Angela, Length of Prescription Drug Payment Times from Part D Plans, Journal of the American Pharmacists Association, 47:6, November /December 2007, 695-701.
Panjabi SS, Panjabi RS, Shepherd MD, Lawson KA, Johnsrud M, Barner J. Extended-Release, Once-Daily Morphine (Avinza) for the Treatment of Chronic Nonmalignant Pain: Effect on Pain, Depressive Symptoms, and Cognition. Pain Medicine 2008, Aug 7.
Shepherd, Marv, Drug Importation and Safety of Drugs Obtained from Canada,The Annals of Pharmacotherapy, Vol.41, (July/August 2007).
Shepherd, Marv, Unprecedented Opportunities for Managed Care Organizations and Community Pharmacies to Work Together, Journal of Managed Care Pharmacy, Vol. 13, No. 5, (June 2007) 426-428.
Shepherd, Marv, Impact of Drug Importation on Community Pharmacy and Patient Care, Journal of the American Pharmacists Association, Vol. 47, No. 3, (May/June 2007) 319-327.
Johnsrud M, Lawson KW and Shepherd MD, Comparison of Mail-Order Versus Community Pharmacy in Plan Sponsor Cost and Member Costs in Two Large Pharmacy Benefit Plans, Journal of Managed Care Pharmacy, Vol.13, No. 2, March/April 2007
Hong S H, Shepherd MD, Scoones D and Wan TTH, Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration, Journal Managed Care Pharmacy, Vol. 11, No. 9, November/December 2005. 746-754.
Shepherd, MD, Drug Quality: Safety Issues and Threats of Drug Importation,California Western Law Review/International Law Journal, Special Edition, Summer 2005. 77-88.
Shepherd, MD Examination of the Relationship Between Direct-to-Consumer Advertising Expenditures and Price, Drug Information Journal, Vol 39, No.1, 2005, 13-24.
Shepherd, MD, Counterfeit Medications and the Pharmacist's Responsibilities, CE Solutions, December 1, 2004, 1-12.
Shepherd, MD Canada Cannot Meet US Drug Supply Needs Product Management Today, July 2004.
Wen LK, Parchman ML and Shepherd MD, Family Support, Diet Barriers among Older Hispanic Adults with Type 2 Diabetes, Clinical Research Methods, Vol 36, No. 6, June 2004, 423-430.
Shepherd, MD Vulnerable Points in the U.S. Drug Distribution System,Supplement to Managed Care, Vol 13, No. 3, March 2004, 25-29
Recent Research Presentations
Dastani H and Shepherd MD, “Predictors of Compliance and Persistence to Statin Therapy Among Texas Medicaid Patients,” poster presentation at the annual meeting of the International Society of Pharmacoeconomics and Outcomes Research, Washington DC, May 16, 2005.
(Scherbakova N., Shepherd, M.D. Makhinova, T.) “Assessment of Internet and Social Networks Use for Professional Purposes by Community Pharmacists,” presented at the American Pharmacists Association Annual Meeting, New Orleans, LA, March 10, 2012
(Nemlekar, P and Shepherd, M.D.) “Assessment of Perceptions of Managed Care Organization Representatives About the Use of Prescription Drug Co-pay Subsidy Coupons” presented at the Academy of Managed Care Pharmacy Annual Meeting, San Francisco, CA, April 19, 2012.
Presentations 2007-2012
“Bitter Pills: Global and National Landscape of Counterfeit and Diverted Drugs,” presented at the Department of Defense, Joint Forces Pharmacy Seminar, San Diego CA, November 1, 2012.
“Worldwide landscape of Counterfeit and Diverted Drugs,” presented at the University of South Carolina, Kennedy Lecture Series, Columbia, SC, October 26, 2012.
“Worldwide Landscape of Counterfeit Drugs,” presented at the University of Texas Alumni Association Quest Organization, Austin, TX, October 2, 2012.
“Accountable Care Organizations (ACOs) and Medical Homes: Pharmacy’s Role” presented at the 60th Annual Pharmacy Practice Seminar, Austin TX, September 16, 2012.
Lecture titled “Worldwide Landscape of Counterfeit Drugs,” presented for the University of Florida, College of Pharmacy, M.S. program via web broadcast, July 14, 2012
“Worldwide Landscape of Counterfeit Drugs,” presented at the Eastern Medicaid Pharmacy Administrators Association, Farmington, PA, October 25, 2011
“Worldwide Landscape of Counterfeit Drugs,” presented at the LAMP a University of Texas Alumni Organization, Austin, TX October 11, 2011.
“Worldwide Landscape of Counterfeit Drugs,” presented at the Annual Meeting of the Austin Area Health-System Pharmacists Association, Austin, TX October 1, 2011
“Role of Nursing in Protecting against Counterfeit Drugs,” web-lecture to members of the Association of Nurses in AIDs Care, September 20, 2011
“Partnership for Safe Medicines Congressional Briefing: Landscape of Counterfeit Drugs” Washington D.C. September 13, 2011
“Worldwide Landscape of Counterfeit Drugs,” presented at NOVA, University of Texas Alumni Association, Austin, TX January 18, 2012
” Managed Care and the Mobile Health Revolution: Use of Social Media for Provision of Patient Care,” Presented at the Academy of Managed Care Educational Conference, Atlanta, GA, October 21, 2011
“Bitter Pill: Growing Threat of Counterfeit Drugs,” Distinguished Faculty Lecture at the Louis C. Littlefield Annual Celebrating Pharmacy Research Excellence Day, University of Texas, Austin, TX, April 17, 2012
“Worldwide Landscape of Counterfeit Drugs,” presented at the Kaiser Permanente Pharmacy Programs & Services Spring Conference, Costa Mesa, CA, April 26, 2012.
“Worldwide Landscape of Counterfeit Drugs,” presented at the University of Texas Alumni College, July 13, 2011.
“Pharmacy Fraud and Crime,” presented at the Texas Pharmacists Association Annual Conference, Fort Worth, TX, June 25, 2011.
“World Wide Landscape of Counterfeit Drugs,” presented at the Texas Department of State Health services, Drugs and Medical Devices Annual Conference, April 13, 2011.
“Worldwide Landscape of Fake Drugs and Product Assurance Methods,” presented at the 3rd International Pharmacy Conference, Kuwait City, Kuwait, February 16, 2011.
“Pharmacoeconmics and Drug Safety for Decision Makers,” presented at the 3rd International Pharmacy Conference, Kuwait City, Kuwait, February 15, 2011
“Current Anti-Counterfeiting Strategies; Are They Enough?” presented at the 2010 International Pharmaceutical Federation and American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, LA, November 16, 2010
“Counterfeit Drugs in South America,” invited presentation at the Latin Media Summit Conference, Miami, FL, October 27, 2010
“Worldwide Landscape of Counterfeit Drugs,” invited presentation, Coy Waller Lecture, School of Pharmacy, University of Mississippi, Oxford, MS October 29, 2010.
“Counterfeit Medications,” invited presentation by the U.S. Consulate General, Rio de Janeiro, Brazil and U.S. Patent and Trademark Office, presented at the University of Sao Paulo, Sao Paulo, Brazil, September 13, 2010.
“Counterfeit Medications,” invited presentation from the U.S. Consulate General, Rio de Janeiro, Brazil and U.S. Patent and Trademark Office, presented at the University of Sao Paulo, Riberiao Preto, Brazil, September14, 2010.
“Worldwide Landscape of Counterfeit Drugs,” presented at the Annual Meeting of the National Coalition of Pharmaceutical Distributors, Las Vegas NV, August 13, 2010.
“Parallel Trade and Reimportation: European and American Perspectives,” presented at the Fifth Global Forum on Pharmaceutical Anti-counterfeiting, Miami, FL, February 24, 2010.
“Alerting the Public” presented at the Pharmaceutical Security Institute Conference: Protecting Public Health through International Partnerships, Beijing, China, November 11, 2009.
“Global Leadership on Drug Anti-counterfeiting,” presented at the China-U.S. Pharmaceuticals and Medical Devices JCCT Subgroup, Second Annual Anti-Counterfeiting Conference, Beijing China, November 10, 2009.
“Worldwide Landscape of Counterfeit Drugs” presented at the Mexican Pharmaceutical Association and Congress Meeting, Cancun, Mexico, October 20, 2009.
“Impact of Globalization on Pharmaceutical Supply Chain Management,” presented at the Annual Scientific Meeting of the U.S. Pharmacopeia, Toronto, Canada, September 23, 2009.
“The Controversy Continues: Rx Pedigrees as an Anti-counterfeiting Tool,” Texas Pharmacy Association Annual Meeting, Rxperts Conference, San Antonio, TX, July 24, 2009
“The Cowboy Scrip: A New Prescription for Pharmacy,” 5th Annual 340 Better Conference, Texas Association of Community Health Centers, Austin, TX, July 13, 2009.
“Disasters, Bioterrorism, Prescription Drug Access and Care,” 5th Annual San Diego Health Policy Conference, Institute for Health Law Studies, California Western School of Law, San Diego, CA March 27, 2009.
“Mexico and Counterfeit Drugs,” University of Texas, UT Explore, March 7, 2009.
“Sources, Threats and Methods to Combat Counterfeit Drugs,” MedImpact 2009 Annual Conference, San Diego, CA, March 4, 2009
“Rxpedigree: Do You Know Where Your Medications Are Coming From, Federal Pharmacy Conference, University of Texas, Austin, TX, March 2, 2009
“Landscape of Counterfeit Drugs,” ARMSRx 2009 Annual Conference, Orlando, FL, February 28, 2009
“Overview and Opportunity,” China-US Pharmaceutical and Medical Devices JCCT Subgroup Anti-Counterfeit Medicines Workshop, Beijing, China, November 18, 2008
“Detection of Counterfeit medicines-Track and Trace Technologies and E-Pedigree,” China-US Pharmaceutical and Medical Devices JCCT Subgroup Anti-Counterfeit Medicines Workshop, Beijing, China, November 18, 2008
“Overview and Opportunity,” presented at the China-US Pharmaceutical and Medical Devices JCCT Subgroup Anti-Counterfeit Medicines Workshop, Beijing, China, November 18, 2008
“Detection of Counterfeit medicines-Track and Trace Technologies and E-Pedigree,” presented at the China-US Pharmaceutical and Medical Devices JCCT Subgroup Anti-Counterfeit Medicines Workshop, Beijing, China, November 18, 2008
“The Threat of Counterfeit Drugs: What Every Pharmacist Needs to Know Now!” presented at the Academy of Managed Care Pharmacy’s 2008 Educational Conference, Kansas, City MO, October 17, 2008.
“Rx pedigree: Do You Know Where Your Medication Is Coming From?” presented at the 56th Pharmacy Practice Seminar (PPS), College of Pharmacy University of Texas, Austin TX, September 28, 2008.
“Code of the West: Application to Pharmacy,” presented at the Annual Meeting of CompleteRx, Inc. League City, TX, July 23, 2008.
“Landscape of Counterfeit Drugs,” presented at the Academy of Managed Care Pharmacy Leadership and Continuing Education Meeting, Alexandria, VA, June 19, 2008
“Partnership for Safe Medicines,” presented at the Fourth Global Forum on Pharmaceutical Anti-counterfeiting, Washington, DC, June 6, 2008
“Counterfeit Drugs; Pharmacist Role in Identifying and Reporting,” presented at the New York State Council of Health-System Pharmacists Annual Assembly, Sagamore Hotel, Bolton Landing, NY, May 2, 2008
“Counterfeit Drugs: Improving the Pharmacist’s Awareness and Role in Safe Sourcing and Indentifying Fake Drugs,” presented for Eli Healthcare Live Audioconference, April 29, 2008
“Utilizing Pharmacoeconomics in the Formulary Decision Process,” presented at the 20th Annual Meeting and Showcase of the Academy of Managed Care Pharmacy, San Francisco, CA, April 18, 2008
“Code of the West: Applications to Pharmacy,” presented at the Texas Society of Health-System Pharmacists 60th Annual Seminar, Dallas, TX, April 4, 2008
“Threat of Counterfeit Drugs,” presented at University of Texas, UT Explore, March 1, 2008
“Drug Pedigree Requirements and Counterfeit Drugs,” presented at the 42nd American Society of Health-System Pharmacists Midyear Meeting and Exhibition, Las Vegas, NV, December 6, 2007
“Counterfeit Drugs: Pharmacist’s Role in Indentifying and Reporting,” presented at the Western New York Society of Health-System Pharmacists, Buffalo, NY, October 25, 2007
“Counterfeit Drugs: Improving Pharmacists’ Awareness,” presented at the annual Meeting of the Texas Association of Community Health Centers, October 20, 2007
“Impact of Drug Importation on Community Pharmacy,” presented at the Annual Meeting National Association of State Pharmacy Executives, Anaheim, CA, October 13, 2007.
“Sources an Threats and Ways to Combat Counterfeit Pharmaceuticals,” Keynote Address presented at the Arkansas Academy of Health-System Pharmacists Fall Seminar, Little Rock AR, October 11, 2007
“Counterfeit Drugs the International Perspective,” presented at the 2007 U.S. Pharmacopeia Annual Scientific Meeting, Tampa, FL, September 27, 2007
“Pharmaceutical Importation Safety Briefing” to the U.S. House Policy Committee: Drug Importation and Patient Safety,” Washington DC, September 26, 2007
“Impact of Drug Importation on Community Pharmacy,” presented at the Midwest State Pharmacy Association Executives Meeting, via conference call and computer link, September 24, 2007
“Impact of Drug Importation on Community Pharmacy and Patient Care,” presented at the American Pharmacists Association Board of Trustees and State Pharmacy Executive Meeting, Washington DC, September 18, 2007
“Code of the West: Applications to the Pharmaceutical Industry,” presented at the Abbott Employee District/Regional Meeting, Woodlands, TX, September 4, 2007
Other Reports and Interviews
“Examination of the Extent Prescription Drug Information is Being Sold, Traded or Exchanged,” Study conducted for the Texas State Board of Pharmacy. Final report submitted on August 26, 2010.
Analysis of Drug Waste from Surgical Procedures in Two Hospitals,” Study conducted for PharMEDium LLC. Final report submitted on July 9, 2010.
Recent Awards
Nominated for the 2012 University Co-op Robert W. Hamilton Book Award, for the textbook Pharmacy Management Leadership, Marketing and Finance. (Jones and Bartlett) 2011 in which I was one of three editors (Chisholm-Burns M.A., Vaillancourt A.M and Shepherd M.D.)
The textbook, Pharmacy Management, Leadership, Marketing and Finance, (co-editors, Marie Chisholm-Burns, Allison Vaillancourt and Marv Shepherd) received the Distinguished 2011 American Medical Writers Association Award in the Health Care Professionals Category.
2010 Legend of Pharmacy Award, presented by the College of Pharmacy Alumni Association, University of Texas, September, 2010.
2007 Best Research Paper Award from the Journal Managed Care Pharmacy. Authors and title of the paper were Michael Johnsrud, Kenneth Lawson and Marv Shepherd, “Comparison of Mail-Order with Community Pharmacy in Plan Sponsor Cost and Member Cost in Two Large Pharmacy Benefit Plans.”
Interviews, Editorial Web Based and Other Publications 2007-2012
Testified before the Texas House Public Health Committee on the Impact Medicaid Managed Care will have on Community Pharmacy, Austin, TX January 24, 2012
U.S. Pharmacopeia, Interview for YouTube “Supply Chain Integrity,” October 14, 2011
Interview for Fox 7 Morning Show, Austin TX, aired October 12, 2010.
“Examination of the Extent Prescription Drug Information is Being Sold, Traded or Exchanged,” Study conducted for the Texas State Board of Pharmacy. Final report submitted on August 26, 2010
“Analysis of Drug Waste from Surgical Procedures in Two Hospitals,” Study conducted for PharMEDium LLC. Final report submitted on July 9, 2010
“Why Steal a Truck Full of Drugs,” Partnership for Safe Medicines, August 26, 2009.
“Counterfeit Drug Sentencing Less Than Adequate,” Partnership for Safe Medicines, August 10, 2009.
“Pharmacists Fight Against Counterfeit Drugs,” Partnership for Safe Medicines, April 24, 2009.
“Strategizing for Safety from Counterfeit Drugs,” Partnership for Safe Medicines, April 20, 2009.
“Leaders in the Fight against Counterfeit Drugs,” Partnership for Safe Medicines, April 13, 2009.
“From Counterfeit Drugs to Fake FDA Agents,” Partnership for Safe Medicines, December 4, 2008.
“Partnership for Safe Medicines Arms Public against Counterfeit Drugs,” Partnership for Safe Medicines, December 1, 2008.
“Counterfeit Drugs and Baby Formula,” Partnership for Safe Medicines, October 2, 2008.
“Easy Ways to Cut Your Drug Costs,” Ultimate Healing and Free Medicines,(Stamford CT: Bottomline Books, 2009) 5-6.
Editorial “Counterfeit Drugs Targeted,” Chain Drug Review, February 2, 2009, p. 41.
Editorial “Confusing Price with Safety,” National Journal, October 11, 2008, 11.
“Pharmaceutical Importation Safety Briefing” to the U.S. House Policy Committee: Drug Importation and Patient Safety,” Washington DC, September 26, 2007
“Licensing Canadian Pharmacies,” Testimony before the Nevada State Board of Pharmacy, Las Vegas, NV, April 20, 2006.
Email address:
Campus location:
US Mail Address:
The University of Texas at Austin
PHR 3.209A
1 University Station, C0850
Austin, TX 78712-0128
FEDEX Address:
107 W. Dean Keeton St.
PHR 3.209A
The University of Texas at Austin
Austin, TX 78712